Ventracor (ASX:VCR) is an international medical technology company that has developed a life-saving
heart pump, the VentrAssist™ left ventricular assist system (LVAS) for patients in cardiac failure. The
company is expects to bring the VentrAssist™ to global markets in record time, and obtaining a
significant share of the potential LVAS market, which independent analysts expect to be valued at over
$US5 billion per year.
Read latest news ann !!!!
this will fly !!!!!!
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)